Swedish private‑equity firm Altor Equity Partners has tabled a bid for Sleep Cycle, the Nasdaq Stockholm‑listed developer of an AI‑driven sleep‑tracking app. The offer sets the share price at Skr24.50, valuing the company at roughly Skr497 million ($53.8 million). The proposal arrives as the health‑tech sector attracts heightened investor interest following strong user growth across wellness apps.

Altor’s price represents a 47 percent premium to Sleep Cycle’s closing price on May 8, signaling confidence that the firm can scale its AI capabilities into broader consumer health markets. Investors have praised the app’s ability to personalize sleep recommendations, a feature that could feed into insurance‑linked wellness programs and bolster recurring revenue streams.

A successful takeover would place Altor among a handful of European funds actively consolidating digital health assets, potentially unlocking synergies with its existing portfolio of telemedicine platforms. The deal also adds a high‑growth, data‑rich asset to Altor’s balance sheet, enhancing its appeal to institutional investors seeking exposure to AI‑enabled health services.

With the bid now open, Sleep Cycle shareholders must decide whether the premium justifies surrendering control of a rapidly expanding brand. Should the offer close, Altor will own a premium AI sleep‑monitoring tool positioned to capitalize on growing consumer willingness to invest in quantified wellness.